Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model f...
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential
About this item
Full title
Author / Creator
Monath, Thomas P , Nichols, Richard , Tussey, Lynda , Scappaticci, Kelly , Pullano, Thaddeus G , Whiteman, Mary D , Vasilakis, Nikos , Rossi, Shannan L , Campos, Rafael Kroon , Azar, Sasha R , Spratt, Heidi M , Seaton, Brent L , Archambault, W Tad , Costecalde, Yanina V , Moore, Evan H , Hawks, Roger J and Fusco, Joan
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Nipah virus (NiV) disease is a bat-borne zoonosis responsible for outbreaks with high lethality and is a priority for vaccine development. With funding from the Coalition of Epidemic Preparedness Innovations (CEPI), we are developing a chimeric vaccine (PHV02) composed of recombinant vesicular stomatitis virus (VSV) expressing the envelope glycopro...
Alternative Titles
Full title
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2690722112
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2690722112
Other Identifiers
ISSN
1553-7374,1553-7366
E-ISSN
1553-7374
DOI
10.1371/journal.ppat.1010658
